We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Smith & Nephew Plc | LSE:SN. | London | Ordinary Share | GB0009223206 | ORD USD0.20 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.20 | 1.14% | 996.80 | 999.60 | 1,000.50 | 1,006.00 | 984.20 | 985.00 | 2,555,392 | 16:35:10 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Ortho,prosth,surg Appl,suply | 5.55B | 263M | 0.3011 | 33.20 | 8.73B |
From May 2019 to May 2024
By Sabela Ojea
Smith & Nephew PLC said Monday that underlying revenue fell 7% in the fourth quarter of the year and it expects a steeper decline in full-year revenue.
The FTSE 100-listed medical-technology said underlying revenue for 2020 is anticipated to fall by 12% compared with the prior year, adding that its trading profit margin will be significantly hit on a year-on-year basis.
The company also said that sales were negatively affected by increased rates of Covid-19 from mid-October onwards, particularly in the U.S. and Europe, where more procedures were postponed due to the reintroduction of restrictions.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
January 11, 2021 02:36 ET (07:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Smith & Nephew Chart |
1 Month Smith & Nephew Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
